Ranbaxy Sues Actavis To Block Generic Absorica Acne Drug
Ranbaxy Inc. launched suit in New Jersey federal court Tuesday alleging pharmaceutical giant Actavis Inc. has infringed its patent for acne drug Absorica by seeking federal approval to launch a generic...To view the full article, register now.
Already a subscriber? Click here to view full article